Overview
Takaharu Suzuki practices in Niigata, Japan. Suzuki is rated as an Advanced expert by MediFind in the treatment of Peripheral T-Cell Lymphoma. Their top areas of expertise are Peripheral T-Cell Lymphoma, Hairy Cell Leukemia (HCL), T-Cell Lymphoma, and Non-Hodgkin Lymphoma.
Their clinical research consists of co-authoring 20 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Peripheral T-Cell Lymphoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Peripheral T-Cell Lymphoma
- Experienced
- Adult T-Cell LeukemiaSuzuki isExperienced. Learn about Adult T-Cell Leukemia.
- Anaplastic Large Cell LymphomaSuzuki isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Angioimmunoblastic T-cell Lymphoma
- Autoimmune Hemolytic AnemiaSuzuki isExperienced. Learn about Autoimmune Hemolytic Anemia.
- B-Cell LymphomaSuzuki isExperienced. Learn about B-Cell Lymphoma.
- Erdheim-Chester DiseaseSuzuki isExperienced. Learn about Erdheim-Chester Disease.